Comparative assessment of therapeutic safety of norcantharidin, N-farnesyloxy-norcantharimide, and N-farnesyl-norcantharimide against Jurkat T cells relative to human normal lymphoblast: A quantitative pilot study

The therapeutic safety of an anticancer drug is one of the most important concerns of the physician treating the cancer patient. Half maximal inhibitory concentration (IC(50)) and hillslope are usually used to represent the strength and sensitivity of an anticancer drug on cancer cells. The therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Ming-Che, Wu, Jin-Yi, Liao, Hui-Fen, Chen, Yu-Jen, Kuo, Cheng-Deng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979836/
https://www.ncbi.nlm.nih.gov/pubmed/27495082
http://dx.doi.org/10.1097/MD.0000000000004467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979836/
https://www.ncbi.nlm.nih.gov/pubmed/27495082
http://dx.doi.org/10.1097/MD.0000000000004467

Ejemplares similares